$AIMD
Ainos, Inc.

2018 Q2 Form 10-Q Financial Statement

#000101476318000015 Filed on August 13, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2017 Q2
Revenue $250.00 $250.5K
YoY Change -99.9%
Cost Of Revenue $707.00 $58.80K
YoY Change -98.8%
Gross Profit -$457.00 $191.7K
YoY Change -100.24%
Gross Profit Margin -182.8% 76.53%
Selling, General & Admin $353.7K $176.9K
YoY Change 99.89% 30.94%
% of Gross Profit 92.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $353.7K $176.9K
YoY Change 99.89% 30.94%
Operating Profit -$354.1K $14.77K
YoY Change -2498.34% -110.93%
Interest Expense $973.00 $1.742K
YoY Change -44.14% 58.8%
% of Operating Profit 11.8%
Other Income/Expense, Net
YoY Change
Pretax Income -$360.0K $10.00K
YoY Change -3700.0% -107.14%
Income Tax
% Of Pretax Income
Net Earnings -$355.1K $13.02K
YoY Change -2826.6% -109.56%
Net Earnings / Revenue -142044.8% 5.2%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.15 $0.01
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.390M $70.00K
YoY Change 1885.71% -77.42%
Cash & Equivalents $1.393M $69.38K
Short-Term Investments
Other Short-Term Assets $60.00K $90.00K
YoY Change -33.33% -35.71%
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $1.458M $156.8K
YoY Change 829.78% -65.44%
LONG-TERM ASSETS
Property, Plant & Equipment $18.39K $35.61K
YoY Change -48.35% -29.03%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $191.6K $206.4K
YoY Change -7.21% 52.91%
TOTAL ASSETS
Total Short-Term Assets $1.458M $156.8K
Total Long-Term Assets $191.6K $206.4K
Total Assets $1.650M $363.3K
YoY Change 354.1% -38.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $190.0K $180.0K
YoY Change 5.56% 80.0%
Accrued Expenses $10.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $510.0K $860.0K
YoY Change -40.7% 8.86%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.003M $1.235M
YoY Change -18.74% 37.68%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.003M $1.235M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.003M $1.235M
YoY Change -18.74% 37.68%
SHAREHOLDERS EQUITY
Retained Earnings -$2.450M -$1.443M
YoY Change 69.85% 68.82%
Common Stock $346.7K $224.4K
YoY Change 54.54% 4.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $588.3K -$871.5K
YoY Change
Total Liabilities & Shareholders Equity $1.650M $363.3K
YoY Change 354.1% -38.31%

Cashflow Statement

Concept 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$355.1K $13.02K
YoY Change -2826.6% -109.56%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$310.0K -$30.00K
YoY Change 933.33% -90.91%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $20.00K
YoY Change -100.0% -66.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$20.00K
YoY Change -100.0% -66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 70.00K
YoY Change -100.0% -83.72%
NET CHANGE
Cash From Operating Activities -310.0K -30.00K
Cash From Investing Activities 0.000 -20.00K
Cash From Financing Activities 0.000 70.00K
Net Change In Cash -310.0K 20.00K
YoY Change -1650.0% -50.0%
FREE CASH FLOW
Cash From Operating Activities -$310.0K -$30.00K
Capital Expenditures $0.00 $20.00K
Free Cash Flow -$310.0K -$50.00K
YoY Change 520.0% -87.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 amar Amount Of Private Placement
AmountOfPrivatePlacement
937500
CY2016Q3 amar Amount Of Private Placement
AmountOfPrivatePlacement
1875000
CY2017Q4 amar Amount Of Private Placement
AmountOfPrivatePlacement
2812500
CY2018Q2 amar Common Stock Shares Outstanding And Reserved
CommonStockSharesOutstandingAndReserved
40237547
amar Dividends Payable Reversed
DividendsPayableReversed
34277
amar Dividends Payable Reversed
DividendsPayableReversed
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34674261
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23156563
CY2017Q4 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
886481
CY2018Q2 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
513356
amar Proceeds From Repayments Of Convertible Debt
ProceedsFromRepaymentsOfConvertibleDebt
-195000
amar Proceeds From Repayments Of Convertible Debt
ProceedsFromRepaymentsOfConvertibleDebt
70000
CY2016Q1 amar Shares Authorized During Period Private Placement
SharesAuthorizedDuringPeriodPrivatePlacement
5000000
CY2016Q3 amar Shares Authorized During Period Private Placement
SharesAuthorizedDuringPeriodPrivatePlacement
10000000
CY2017Q4 amar Shares Authorized During Period Private Placement
SharesAuthorizedDuringPeriodPrivatePlacement
15000000
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
188251
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
159300
CY2018Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
CY2017Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2691661
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2123205
CY2018Q2 us-gaap Assets
Assets
1649535
CY2017Q4 us-gaap Assets
Assets
2293834
CY2018Q2 us-gaap Assets Current
AssetsCurrent
1457967
CY2017Q4 us-gaap Assets Current
AssetsCurrent
2084451
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;"> <tr> <td style="width:27pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div></div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;">Basis of presentation.</div> The accompanying financial statements, which should be read in conjunction with the audited financial statements and footnotes included in the Company's Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>as filed with the Securities and Exchange Commission on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 17, 2018, </div>have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2018 </div>are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be expected for the full year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018.</div></div> </td> </tr> </table></div>
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1393474
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1980015
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134125
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69376
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-586541
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-64749
CY2018Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34674261
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23156563
CY2018Q2 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
2827305
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
346742
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
231565
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
707
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
58801
us-gaap Cost Of Revenue
CostOfRevenue
44046
us-gaap Cost Of Revenue
CostOfRevenue
58801
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
178125
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
CY2018Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
CY2017Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
58135
CY2018Q2 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
301773
CY2017Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
777258
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
173179
CY2017Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
182386
CY2018Q2 us-gaap Gross Profit
GrossProfit
-457
CY2017Q2 us-gaap Gross Profit
GrossProfit
191701
us-gaap Gross Profit
GrossProfit
12794
us-gaap Gross Profit
GrossProfit
191701
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2018Q2 us-gaap Interest Expense
InterestExpense
973
CY2017Q2 us-gaap Interest Expense
InterestExpense
1742
us-gaap Interest Expense
InterestExpense
2353
us-gaap Interest Expense
InterestExpense
5701
us-gaap Interest Paid Net
InterestPaidNet
us-gaap Interest Paid Net
InterestPaidNet
CY2018Q2 us-gaap Inventory Net
InventoryNet
CY2017Q4 us-gaap Inventory Net
InventoryNet
22666
CY2018Q2 us-gaap Liabilities
Liabilities
1003380
CY2017Q4 us-gaap Liabilities
Liabilities
1823039
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1649535
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2293834
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1003380
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1823039
CY2018Q2 us-gaap Minority Interest
MinorityInterest
57853
CY2017Q4 us-gaap Minority Interest
MinorityInterest
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-195000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
120625
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2108
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25786
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-389433
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-159588
CY2018Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-23313
CY2017Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-18321
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-331799
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13024
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-524229
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-175948
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2018Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
353682
CY2017Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
176935
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
552991
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
361948
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-354139
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
14766
us-gaap Operating Income Loss
OperatingIncomeLoss
-540197
us-gaap Operating Income Loss
OperatingIncomeLoss
-170247
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2108
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
25786
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
64493
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23635
CY2017Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
50625
CY2017Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
93750
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
50625
CY2018Q2 us-gaap Profit Loss
ProfitLoss
-355112
CY2017Q2 us-gaap Profit Loss
ProfitLoss
13024
us-gaap Profit Loss
ProfitLoss
-542550
us-gaap Profit Loss
ProfitLoss
-175948
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18389
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26997
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2450101
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1883975
CY2018Q2 us-gaap Revenues
Revenues
250
CY2017Q2 us-gaap Revenues
Revenues
250502
us-gaap Revenues
Revenues
56840
us-gaap Revenues
Revenues
250502
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
353682
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
176935
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
552991
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
361948
us-gaap Stock Issued1
StockIssued1
496736
us-gaap Stock Issued1
StockIssued1
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
588302
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
470795
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
646155
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
470795
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34635799
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22431427
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33943536
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22353918

Files In Submission

Name View Source Status
0001014763-18-000015-index-headers.html Edgar Link pending
0001014763-18-000015-index.html Edgar Link pending
0001014763-18-000015.txt Edgar Link pending
0001014763-18-000015-xbrl.zip Edgar Link pending
amar-20180630.xml Edgar Link completed
amar-20180630.xsd Edgar Link pending
amar-20180630_cal.xml Edgar Link unprocessable
amar-20180630_def.xml Edgar Link unprocessable
amar-20180630_lab.xml Edgar Link unprocessable
amar-20180630_pre.xml Edgar Link unprocessable
exhibit_31-1a.htm Edgar Link pending
exhibit_31-1b.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q_06302018.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending